Proteoliposomes as drug carriers

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3722

Patent

active

048730890

ABSTRACT:
A process for the preparation of proteoliposomes comprising: (1) mixing a fusogen with lipid components used to form unilamellar lipid vesicles to thereby form fusogenic unilamellar lipid vesicles; and (2) activating the fusogenic unilamellar lipid vesicles in the presence of integral membrane proteins to thereby form fusogenic proteoliposomes, wherein the fusogenic unilamellar lipid vesicles are activated by lowering the temperature of the mixture of fusogenic unilamellar lipid vesicles and integral membrane proteins to at or below the phase transition temperature of the fusogenic unilamellar lipid vesicles. A proteoliposome, a medicament comprising the proteoliposome and a drug or other biologically or physiologically active agent, and a method of treatment comprising administering the medicament to an afflicted host are also disclosed. The proteoliposomes are larger than conventional proteoliposomes and are more stable than conventional unilamellar lipid vesicles.

REFERENCES:
patent: 3937668 (1976-02-01), Zolle
patent: 4560665 (1985-12-01), Nakae et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Proteoliposomes as drug carriers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Proteoliposomes as drug carriers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteoliposomes as drug carriers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1956513

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.